If you need more lookups,
subscriptions start at $34 USD/month.
Rob Windsor Location
Boston, MA, US
Rob Windsor Work
2026 -now Managing Director @
2024 -2026 Chief Business Officer @
2023 -2024 Head of Investor Relations @
2021 -2023 Head Of Investor Relations @ Sigilon Therapeutics (Acquired by Eli Lilly 9/23)
2019 -2021 Managing Director - Financial Services Sales @
2013 -2018 Senior Vice President - Institutional Equity Sales @
2011 -2013 Vice President - Institutional Equity Sales @
2005 -2011 Director - Institutional Equity Sales @
1999 -2001 Commercial Credit Analyst @
Rob Windsor Education
New York Law School
Juris Doctor (Banking, Corporate, Finance, and Securities Law)
2002-2005
University of Colorado at Boulder
Bachelor of Arts (B.A.) (Liberal Arts and Sciences/Liberal Studies)
1995-1999
Rob Windsor Skills
Equity Capital Markets
Written Communication
Entrepreneurship
Corporate Law
Legal Compliance
Cross-functional Team Leadership
Presentation Skills
invest
Financial Analysis
Client Relations
Strategic Thinking
Financial Services
Analytical Skills
Investor Relations
Capital Markets
Investments
Investment Banking
Equities
Asset Management
Bloomberg
Rob Windsor Summary
Rob Windsor, based in Boston, MA, US, is currently a Managing Director at CFGO. Rob Windsor brings experience from previous roles at LifeSci Partners, Seres Therapeutics, Sigilon Therapeutics (Acquired by Eli Lilly 9/23) and William O'Neil + Co., Inc.. Rob Windsor holds a 2002 - 2005 Juris Doctor in Banking, Corporate, Finance, and Securities Law @ New York Law School. With a robust skill set that includes Equity Capital Markets, Written Communication, Entrepreneurship, Corporate Law, Legal Compliance and more. Rob Windsor has 3 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Rob Windsor?
Find contact details for 700 million professionals.